Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunteers
NCT02318758 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2015-03-24
Summary
A study to assess the interaction of acohol and oral treprostinil.
Conditions
- Healthy
Interventions
- DRUG
-
UT-15C
sustained release oral treprostinil
- OTHER
-
ethanol
Absolut 100 vodka
Sponsors & Collaborators
-
United Therapeutics
lead INDUSTRY
Principal Investigators
-
Aziz Laurent, MD · PPD Development, LP
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2014-10-31
- Completion
- 2014-12-31
Countries
- United States
Study Locations
More Related Trials
-
Three Times Daily Dosing of UT-15C
NCT01746485 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male Subjects
NCT02259985 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Effects of Oral DMAA
NCT01765933 ·Status: COMPLETED ·Phase: NA
-
Terbutaline Concentrations in Blood and Urine
NCT00914797 ·Status: UNKNOWN ·Phase: PHASE4
-
Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions
NCT01380457 ·Status: COMPLETED ·Phase: PHASE1
-
Grape Polyphenol Kinetics in Humans
NCT01751750 ·Status: COMPLETED ·Phase: NA
-
L-Citrulline and Endothelial Function
NCT05722860 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Pharmacological Effects of a Standardized Cannabis Preparation
NCT04841993 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic and Pharmacodynamic Effects of Passive Cannabis Inhalation
NCT01798186 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Methylphenidate on Performance in the Cold
NCT04283877 ·Status: UNKNOWN ·Phase: PHASE4
-
Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain
NCT02569073 ·Status: WITHDRAWN ·Phase: PHASE4
-
Evaluating a Potential Pharmacokinetic Kratom-oxycodone Interaction Concurrent With Clinical Endpoints
NCT05846451 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Comparison of the Pharmacokinetics of Three Generic Medications and Their Respective Brand Preparations
NCT01400165 ·Status: UNKNOWN ·Phase: PHASE1
-
Histamines and Central Hemodynamics
NCT07285031 ·Status: RECRUITING ·Phase: NA
-
The Development of Oral Nalbuphine Dosage Form
NCT00924079 ·Status: UNKNOWN ·Phase: NA
-
Synthetic THC And Blood Pressure
NCT07231965 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate
NCT02135965 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions
NCT01448772 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Caffeine on Pain-Based Pacing During a Cycling Time-Trial
NCT02115763 ·Status: COMPLETED ·Phase: PHASE1
-
Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults
NCT03738943 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Cannabidiol Effects on Cardiovascular System and Exercise Responses
NCT05232123 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
The Effect of Beetroot Juice on Plasma Trimethylamine N-oxide Concentration
NCT05004935 ·Status: UNKNOWN ·Phase: NA
-
¹³C-Methacetin Breath Test (MBT) Methodology Study
NCT01205074 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response
NCT01577459 ·Status: COMPLETED ·Phase: PHASE1
-
Histamine as a Molecular Transducer of Adaptation to Exercise
NCT05206227 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1